Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
Chia-Chun ChiangXuemin FangZsolt HorvathFrancois CadiouAlexandre UraniWeijie PohHiroto NarimatsuYu ChengDavid W DodickPublished in: Neurology (2023)
This study provides Class IV evidence that for patients with migraine, selected acute medications (e.g., triptans, ergots, anti-emetics) are associated with higher odds of user-rated positive response than ibuprofen.